非酒精性脂肪性肝病的治疗研究

非酒精性脂肪性肝病（NAFLD）是一种由胰岛素抵抗、肝脏炎症、高脂血症等多种原因导致的慢性肝脏疾病。NAFLD现已成为欧美等发达国家以及我国最常见的慢性肝病之一。根据流行病学调查显示，NAFLD在我国发病率约为15%，而在欧美等发达国家发病率已超过20%。NAFLD死亡率高于普通人群，因此针对NAFLD的有效治疗十分重要。目前在临床上针对其治疗主要包括生活方式干预、药物治疗以及外科手术治疗。本文结合国内外文献对NAFLD的治疗研究进行综述。

Treatment of Non-alcoholic Fatty Liver Disease

Abstract:Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease caused by various factors such as insulin resistance, liver inflammation, and hyperlipidemia. NAFLD has become one of the most common chronic liver diseases in developed countries such as Europe and the United States. According to epidemiological surveys, the incidence of NAFLD in China is about 15%, and the incidence rate in developed countries such as Europe and the United States has exceeded 20%. The mortality rate of NAFLD is higher than that of the general population, so effective treatment for NAFLD is very important. Currently, clinical treatment for its main treatment includes lifestyle intervention, drug treatment and surgical treatment. This article reviews the treatment of NAFLD in combination with domestic and foreign literature.